Partnering with families to improve dialysis care
The Standardizing Care to Improve Outcomes in Pediatric Endstage Kidney Disease (SCOPE) collaborative prevents infections in children and adolescents on peritoneal dialysis and hemodialysis using large-scale collaboration to identify and spread effective interventions across pediatric care settings.
Organizations participating in SCOPE help families provide essential and complex care in the home for children with kidney disease. The evidence shows that patients at SCOPE centers:
- Have reduced risk of infections.
- Have fewer hospitalizations.
- Maintain health for transplant.
- Maintain normal school and family life.
SCOPE's impact, by the numbers
- 552 PD-related hospitalizations prevented and 671 HD-related hospitalizations prevented.
- 917 peritoneal infections prevented and 969 access-related bloodstream infections prevented.
- $16,572,849 million saved hospitalization costs for PD-related infections and $20,566,775 million saved hospitalization costs for HD-related infections.
- The peritonitis rate dropped 52% with an 85% reduction in hemodialysis BSI rate for the original 16 HD centers.
National recognition
SCOPE is recognized as evidence-based, data-driven, effective, and methodologically robust by leading organizations:
- SCOPE participation earns points in the U.S. News and World Report children’s hospital survey.
- SCOPE’s scholarly output includes 45 presentations at national and international meetings and 16 publications in leading journals including Kidney International, The Clinical Journal of the American Society of Nephrology, and Pediatric Nephrology.
Eligibility and enrollment
All CHA member hospitals are eligible to participate. New participants begin the collaborative semi-annually; July and January. Enrollment deadlines are June 30 or December 31, respectively.
PD - peritoneal dialysis; HD - hemodialysis
1,223
hospitalizations prevented
$37M
saved in prevented hospitalizations
1,886
dialysis-related infections prevented
